Monitoring Endocrine Complications of Immunotherapy: A Screening Tool

Introduction The advent of immunotherapy has revolutionized cancer therapy in recent years. Immunotherapy using monoclonal antibodies against checkpoint molecules, including programmed death (PD)-1, PD ligand (PD-L)1, and cytotoxic T-lymphocyte antigen 4 (CTLA)-4, has become a cornerstone in cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Majety, Priyanka, Groysman, Anna, Seery, Virginia, Shea, Meghan, Hou, Runhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375107/
https://www.ncbi.nlm.nih.gov/pubmed/35974849
http://dx.doi.org/10.7759/cureus.26859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375107/
https://www.ncbi.nlm.nih.gov/pubmed/35974849
http://dx.doi.org/10.7759/cureus.26859

Ejemplares similares